These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25953320)

  • 21. Tubular aggregate myopathy caused by a novel mutation in the cytoplasmic domain of STIM1.
    Okuma H; Saito F; Mitsui J; Hara Y; Hatanaka Y; Ikeda M; Shimizu T; Matsumura K; Shimizu J; Tsuji S; Sonoo M
    Neurol Genet; 2016 Feb; 2(1):e50. PubMed ID: 27066587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dominant STIM1 mutation causes Stormorken syndrome.
    Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
    Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies.
    Goswami A; Jesse CM; Chandrasekar A; Bushuven E; Vollrath JT; Dreser A; Katona I; Beyer C; Johann S; Feller AC; Grond M; Wagner S; Nikolin S; Troost D; Weis J
    Neuropathol Appl Neurobiol; 2015 Apr; 41(3):304-18. PubMed ID: 24957221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy.
    Barone V; Del Re V; Gamberucci A; Polverino V; Galli L; Rossi D; Costanzi E; Toniolo L; Berti G; Malandrini A; Ricci G; Siciliano G; Vattemi G; Tomelleri G; Pierantozzi E; Spinozzi S; Volpi N; Fulceri R; Battistutta R; Reggiani C; Sorrentino V
    Hum Mutat; 2017 Dec; 38(12):1761-1773. PubMed ID: 28895244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
    Böhm J; Laporte J
    Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The origin of tubular aggregates in human myopathies.
    Chevessier F; Bauché-Godard S; Leroy JP; Koenig J; Paturneau-Jouas M; Eymard B; Hantaï D; Verdière-Sahuqué M
    J Pathol; 2005 Nov; 207(3):313-23. PubMed ID: 16178054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of the Ca
    Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy.
    Conte E; Pannunzio A; Imbrici P; Camerino GM; Maggi L; Mora M; Gibertini S; Cappellari O; De Luca A; Coluccia M; Liantonio A
    Front Cell Dev Biol; 2021; 9():635063. PubMed ID: 33718371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle magnetic resonance characterization of STIM1 tubular aggregate myopathy using unsupervised learning.
    Lupi A; Spolaor S; Favero A; Bello L; Stramare R; Pegoraro E; Nobile MS
    PLoS One; 2023; 18(5):e0285422. PubMed ID: 37155641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis.
    Garibaldi M; Fattori F; Riva B; Labasse C; Brochier G; Ottaviani P; Sacconi S; Vizzaccaro E; Laschena F; Romero NB; Genazzani A; Bertini E; Antonini G
    Clin Genet; 2017 May; 91(5):780-786. PubMed ID: 27882542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: Novel STIM1 Gain-of-Function Mutation in a Patient With TAM/STRMK and Immunological Involvement.
    de la Fuente-Munoz E; Van Den Rym A; García-Solis B; Ochoa Grullón J; Guevara-Hoyer K; Fernández-Arquero M; Galán Dávila L; Matías-Guiú J; Sánchez-Ramón S; Pérez de Diego R
    Front Immunol; 2022; 13():917601. PubMed ID: 35812399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
    Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
    Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubular aggregate myopathy: a case report.
    Kim NR; Suh YL
    J Korean Med Sci; 2003 Feb; 18(1):135-40. PubMed ID: 12589105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy.
    Böhm J; Lornage X; Chevessier F; Birck C; Zanotti S; Cudia P; Bulla M; Granger F; Bui MT; Sartori M; Schneider-Gold C; Malfatti E; Romero NB; Mora M; Laporte J
    Acta Neuropathol; 2018 Jan; 135(1):149-151. PubMed ID: 29039140
    [No Abstract]   [Full Text] [Related]  

  • 38. Visualizing the store-operated channel complex assembly in real time: identification of SERCA2 as a new member.
    Sampieri A; Zepeda A; Asanov A; Vaca L
    Cell Calcium; 2009 May; 45(5):439-46. PubMed ID: 19327826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
    Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of STIM1 in the proteinase-activated receptor 1-mediated Ca2+ influx in vascular endothelial cells.
    Hirano K; Hirano M; Hanada A
    J Cell Biochem; 2009 Oct; 108(2):499-507. PubMed ID: 19626660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.